Intrinsic Value of S&P & Nasdaq Contact Us

Item 9 Labs Corp. INLB OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
24/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Item 9 Labs Corp. (INLB) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - Specialty & Generic industry. The company is headquartered in Phoenix, AZ, United States. The current CEO is Jeffrey I. Rassas.

INLB has IPO date of 2012-01-25, 97 full-time employees, listed on the Other OTC, a market capitalization of $70.18K.

About Item 9 Labs Corp.

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells medical and adult-use cannabis dispensary franchises under the Unity Rd brand name. Item 9 Labs Corp. is headquartered in Phoenix, Arizona.

📍 2727 North 3rd Street, Phoenix, AZ 85004 📞 833 867 6337
Company Details
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CountryUnited States
ExchangeOther OTC
CurrencyUSD
IPO Date2012-01-25
CEOJeffrey I. Rassas
Employees97
Trading Info
Current Price$0.00
Market Cap$70.18K
52-Week Range0.0001-0.0001
Beta0.07
ETFNo
ADRNo
CUSIP46564C203
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message